Global Dermatology OTC Medications Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 111

Published Date: 05 Jun 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Dermatology OTC Medications market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Dermatology OTC Medications size is estimated to be XX million in 2021 from USD 12770 million in 2020, with a change of XX% between 2020 and 2021. The global Dermatology OTC Medications market size is expected to grow at a CAGR of 3.2% for the next five years.

Market segmentation
Dermatology OTC Medications market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    External Use
    Oral

Market segment by Application can be divided into
    Hospital
    Drug Store
    Other

The key market players for global Dermatology OTC Medications market are listed below:
    Bayer
    GSK
    Teva
    Johnson & Johnson
    Novartis
    Mylan
    Sun Pharmaceutical
    Aurobindo
    Galderma
    CR SANJIU
    Dr. Reddy's
    Lupin
    Bausch Health
    Cipla
    Qilu Pharmaceutical
    Almirall
    Lingrui

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Dermatology OTC Medications product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dermatology OTC Medications, with price, sales, revenue and global market share of Dermatology OTC Medications from 2019 to 2021.
Chapter 3, the Dermatology OTC Medications competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dermatology OTC Medications breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Dermatology OTC Medications market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Dermatology OTC Medications sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Dermatology OTC Medications Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Dermatology OTC Medications Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 External Use
        1.2.3 Oral
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Dermatology OTC Medications Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Hospital
        1.3.3 Drug Store
        1.3.4 Other
    1.4 Global Dermatology OTC Medications Market Size & Forecast
        1.4.1 Global Dermatology OTC Medications Sales in Value (2016-2026))
        1.4.2 Global Dermatology OTC Medications Sales in Volume (2016-2026)
        1.4.3 Global Dermatology OTC Medications Price by Type (2016-2026) & (USD/Unit)
    1.5 Global Dermatology OTC Medications Production Capacity Analysis
        1.5.1 Global Dermatology OTC Medications Total Production Capacity (2016-2026)
        1.5.2 Global Dermatology OTC Medications Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Dermatology OTC Medications Market Drivers
        1.6.2 Dermatology OTC Medications Market Restraints
        1.6.3 Dermatology OTC Medications Trends Analysis

2 Manufacturers Profiles
    2.1 Bayer
        2.1.1 Bayer Details
        2.1.2 Bayer Major Business
        2.1.3 Bayer Dermatology OTC Medications Product and Services
        2.1.4 Bayer Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 GSK
        2.2.1 GSK Details
        2.2.2 GSK Major Business
        2.2.3 GSK Dermatology OTC Medications Product and Services
        2.2.4 GSK Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Teva
        2.3.1 Teva Details
        2.3.2 Teva Major Business
        2.3.3 Teva Dermatology OTC Medications Product and Services
        2.3.4 Teva Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Johnson & Johnson
        2.4.1 Johnson & Johnson Details
        2.4.2 Johnson & Johnson Major Business
        2.4.3 Johnson & Johnson Dermatology OTC Medications Product and Services
        2.4.4 Johnson & Johnson Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Novartis
        2.5.1 Novartis Details
        2.5.2 Novartis Major Business
        2.5.3 Novartis Dermatology OTC Medications Product and Services
        2.5.4 Novartis Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 Mylan
        2.6.1 Mylan Details
        2.6.2 Mylan Major Business
        2.6.3 Mylan Dermatology OTC Medications Product and Services
        2.6.4 Mylan Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 Sun Pharmaceutical
        2.7.1 Sun Pharmaceutical Details
        2.7.2 Sun Pharmaceutical Major Business
        2.7.3 Sun Pharmaceutical Dermatology OTC Medications Product and Services
        2.7.4 Sun Pharmaceutical Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 Aurobindo
        2.8.1 Aurobindo Details
        2.8.2 Aurobindo Major Business
        2.8.3 Aurobindo Dermatology OTC Medications Product and Services
        2.8.4 Aurobindo Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 Galderma
        2.9.1 Galderma Details
        2.9.2 Galderma Major Business
        2.9.3 Galderma Dermatology OTC Medications Product and Services
        2.9.4 Galderma Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.10 CR SANJIU
        2.10.1 CR SANJIU Details
        2.10.2 CR SANJIU Major Business
        2.10.3 CR SANJIU Dermatology OTC Medications Product and Services
        2.10.4 CR SANJIU Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.11 Dr. Reddy's
        2.11.1 Dr. Reddy's Details
        2.11.2 Dr. Reddy's Major Business
        2.11.3 Dr. Reddy's Dermatology OTC Medications Product and Services
        2.11.4 Dr. Reddy's Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.12 Lupin
        2.12.1 Lupin Details
        2.12.2 Lupin Major Business
        2.12.3 Lupin Dermatology OTC Medications Product and Services
        2.12.4 Lupin Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.13 Bausch Health
        2.13.1 Bausch Health Details
        2.13.2 Bausch Health Major Business
        2.13.3 Bausch Health Dermatology OTC Medications Product and Services
        2.13.4 Bausch Health Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.14 Cipla
        2.14.1 Cipla Details
        2.14.2 Cipla Major Business
        2.14.3 Cipla Dermatology OTC Medications Product and Services
        2.14.4 Cipla Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.15 Qilu Pharmaceutical
        2.15.1 Qilu Pharmaceutical Details
        2.15.2 Qilu Pharmaceutical Major Business
        2.15.3 Qilu Pharmaceutical Dermatology OTC Medications Product and Services
        2.15.4 Qilu Pharmaceutical Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.16 Almirall
        2.16.1 Almirall Details
        2.16.2 Almirall Major Business
        2.16.3 Almirall Dermatology OTC Medications Product and Services
        2.16.4 Almirall Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.17 Lingrui
        2.17.1 Lingrui Details
        2.17.2 Lingrui Major Business
        2.17.3 Lingrui Dermatology OTC Medications Product and Services
        2.17.4 Lingrui Dermatology OTC Medications Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Dermatology OTC Medications Sales by Manufacturer
    3.1 Global Dermatology OTC Medications Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Dermatology OTC Medications Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Dermatology OTC Medications
    3.4 Market Concentration Rate
        3.4.1 Top 3 Dermatology OTC Medications Manufacturer Market Share
        3.4.2 Top 6 Dermatology OTC Medications Manufacturer Market Share
    3.5 Global Dermatology OTC Medications Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Dermatology OTC Medications Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Dermatology OTC Medications Market Size by Region
        4.1.1 Global Dermatology OTC Medications Sales in Volume by Region (2016-2026)
        4.1.2 Global Dermatology OTC Medications Revenue by Region (2016-2026)
    4.2 North America Dermatology OTC Medications Revenue (2016-2026)
    4.3 Europe Dermatology OTC Medications Revenue (2016-2026)
    4.4 Asia-Pacific Dermatology OTC Medications Revenue (2016-2026)
    4.5 South America Dermatology OTC Medications Revenue (2016-2026)
    4.6 Middle East and Africa Dermatology OTC Medications Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Dermatology OTC Medications Sales in Volume by Type (2016-2026)
    5.2 Global Dermatology OTC Medications Revenue by Type (2016-2026)
    5.3 Global Dermatology OTC Medications Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Dermatology OTC Medications Sales in Volume by Application (2016-2026)
    6.2 Global Dermatology OTC Medications Revenue by Application (2016-2026)
    6.3 Global Dermatology OTC Medications Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Dermatology OTC Medications Sales by Type (2016-2026)
    7.2 North America Dermatology OTC Medications Sales by Application (2016-2026)
    7.3 North America Dermatology OTC Medications Market Size by Country
        7.3.1 North America Dermatology OTC Medications Sales in Volume by Country (2016-2026)
        7.3.2 North America Dermatology OTC Medications Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Dermatology OTC Medications Sales by Type (2016-2026)
    8.2 Europe Dermatology OTC Medications Sales by Application (2016-2026)
    8.3 Europe Dermatology OTC Medications Market Size by Country
        8.3.1 Europe Dermatology OTC Medications Sales in Volume by Country (2016-2026)
        8.3.2 Europe Dermatology OTC Medications Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Dermatology OTC Medications Sales by Type (2016-2026)
    9.2 Asia-Pacific Dermatology OTC Medications Sales by Application (2016-2026)
    9.3 Asia-Pacific Dermatology OTC Medications Market Size by Region
        9.3.1 Asia-Pacific Dermatology OTC Medications Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Dermatology OTC Medications Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Dermatology OTC Medications Sales by Type (2016-2026)
    10.2 South America Dermatology OTC Medications Sales by Application (2016-2026)
    10.3 South America Dermatology OTC Medications Market Size by Country
        10.3.1 South America Dermatology OTC Medications Sales in Volume by Country (2016-2026)
        10.3.2 South America Dermatology OTC Medications Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Dermatology OTC Medications Sales by Type (2016-2026)
    11.2 Middle East & Africa Dermatology OTC Medications Sales by Application (2016-2026)
    11.3 Middle East & Africa Dermatology OTC Medications Market Size by Country
        11.3.1 Middle East & Africa Dermatology OTC Medications Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Dermatology OTC Medications Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Dermatology OTC Medications Typical Distributors
    12.3 Dermatology OTC Medications Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Dermatology OTC Medications Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Dermatology OTC Medications Revenue by Application, (USD Million), 2021-2026
    Table 3. Bayer Basic Information, Manufacturing Base and Competitors
    Table 4. Bayer Major Business
    Table 5. Bayer Dermatology OTC Medications Product and Services
    Table 6. Bayer Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. GSK Basic Information, Manufacturing Base and Competitors
    Table 8. GSK Major Business
    Table 9. GSK Dermatology OTC Medications Product and Services
    Table 10. GSK Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. Teva Basic Information, Manufacturing Base and Competitors
    Table 12. Teva Major Business
    Table 13. Teva Dermatology OTC Medications Product and Services
    Table 14. Teva Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 16. Johnson & Johnson Major Business
    Table 17. Johnson & Johnson Dermatology OTC Medications Product and Services
    Table 18. Johnson & Johnson Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. Novartis Basic Information, Manufacturing Base and Competitors
    Table 20. Novartis Major Business
    Table 21. Novartis Dermatology OTC Medications Product and Services
    Table 22. Novartis Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. Mylan Basic Information, Manufacturing Base and Competitors
    Table 24. Mylan Major Business
    Table 25. Mylan Dermatology OTC Medications Product and Services
    Table 26. Mylan Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 27. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 28. Sun Pharmaceutical Major Business
    Table 29. Sun Pharmaceutical Dermatology OTC Medications Product and Services
    Table 30. Sun Pharmaceutical Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 31. Aurobindo Basic Information, Manufacturing Base and Competitors
    Table 32. Aurobindo Major Business
    Table 33. Aurobindo Dermatology OTC Medications Product and Services
    Table 34. Aurobindo Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 35. Galderma Basic Information, Manufacturing Base and Competitors
    Table 36. Galderma Major Business
    Table 37. Galderma Dermatology OTC Medications Product and Services
    Table 38. Galderma Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 39. CR SANJIU Basic Information, Manufacturing Base and Competitors
    Table 40. CR SANJIU Major Business
    Table 41. CR SANJIU Dermatology OTC Medications Product and Services
    Table 42. CR SANJIU Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 43. Dr. Reddy's Basic Information, Manufacturing Base and Competitors
    Table 44. Dr. Reddy's Major Business
    Table 45. Dr. Reddy's Dermatology OTC Medications Product and Services
    Table 46. Dr. Reddy's Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 47. Lupin Basic Information, Manufacturing Base and Competitors
    Table 48. Lupin Major Business
    Table 49. Lupin Dermatology OTC Medications Product and Services
    Table 50. Lupin Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 51. Bausch Health Basic Information, Manufacturing Base and Competitors
    Table 52. Bausch Health Major Business
    Table 53. Bausch Health Dermatology OTC Medications Product and Services
    Table 54. Bausch Health Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 55. Cipla Basic Information, Manufacturing Base and Competitors
    Table 56. Cipla Major Business
    Table 57. Cipla Dermatology OTC Medications Product and Services
    Table 58. Cipla Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 59. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 60. Qilu Pharmaceutical Major Business
    Table 61. Qilu Pharmaceutical Dermatology OTC Medications Product and Services
    Table 62. Qilu Pharmaceutical Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 63. Almirall Basic Information, Manufacturing Base and Competitors
    Table 64. Almirall Major Business
    Table 65. Almirall Dermatology OTC Medications Product and Services
    Table 66. Almirall Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 67. Lingrui Basic Information, Manufacturing Base and Competitors
    Table 68. Lingrui Major Business
    Table 69. Lingrui Dermatology OTC Medications Product and Services
    Table 70. Lingrui Dermatology OTC Medications Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 71. Global Dermatology OTC Medications Sales by Manufacturer (2019-2021e) & (M Units)
    Table 72. Global Dermatology OTC Medications Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 73. Market Position of Manufacturers in Dermatology OTC Medications, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 74. Global Dermatology OTC Medications Production Capacity by Company, (M Units): 2020 VS 2021
    Table 75. Head Office and Dermatology OTC Medications Production Site of Key Manufacturer
    Table 76. Dermatology OTC Medications New Entrant and Capacity Expansion Plans
    Table 77. Dermatology OTC Medications Mergers & Acquisitions in the Past Five Years
    Table 78. Global Dermatology OTC Medications Sales by Region (2016-2021e) & (M Units)
    Table 79. Global Dermatology OTC Medications Sales by Region (2021-2026) & (M Units)
    Table 80. Global Dermatology OTC Medications Revenue by Region (2016-2021e) & (USD Million)
    Table 81. Global Dermatology OTC Medications Revenue by Region (2021-2026) & (USD Million)
    Table 82. Global Dermatology OTC Medications Sales by Type (2016-2021e) & (M Units)
    Table 83. Global Dermatology OTC Medications Sales by Type (2021-2026) & (M Units)
    Table 84. Global Dermatology OTC Medications Revenue by Type (2016-2021e) & (USD Million)
    Table 85. Global Dermatology OTC Medications Revenue by Type (2021-2026) & (USD Million)
    Table 86. Global Dermatology OTC Medications Price by Type (2016-2021e) & (USD/Unit)
    Table 87. Global Dermatology OTC Medications Price by Type (2021-2026) & (USD/Unit)
    Table 88. Global Dermatology OTC Medications Sales by Application (2016-2021e) & (M Units)
    Table 89. Global Dermatology OTC Medications Sales by Application (2021-2026) & (M Units)
    Table 90. Global Dermatology OTC Medications Revenue by Application (2016-2021e) & (USD Million)
    Table 91. Global Dermatology OTC Medications Revenue by Application (2021-2026) & (USD Million)
    Table 92. Global Dermatology OTC Medications Price by Application (2016-2021e) & (USD/Unit)
    Table 93. Global Dermatology OTC Medications Price by Application (2021-2026) & (USD/Unit)
    Table 94. North America Dermatology OTC Medications Sales by Country (2016-2021e) & (M Units)
    Table 95. North America Dermatology OTC Medications Sales by Country (2021-2026) & (M Units)
    Table 96. North America Dermatology OTC Medications Revenue by Country (2016-2021e) & (USD Million)
    Table 97. North America Dermatology OTC Medications Revenue by Country (2021-2026) & (USD Million)
    Table 98. North America Dermatology OTC Medications Sales by Type (2016-2021e) & (M Units)
    Table 99. North America Dermatology OTC Medications Sales by Type (2021-2026) & (M Units)
    Table 100. North America Dermatology OTC Medications Sales by Application (2016-2021e) & (M Units)
    Table 101. North America Dermatology OTC Medications Sales by Application (2021-2026) & (M Units)
    Table 102. Europe Dermatology OTC Medications Sales by Country (2016-2021e) & (M Units)
    Table 103. Europe Dermatology OTC Medications Sales by Country (2021-2026) & (M Units)
    Table 104. Europe Dermatology OTC Medications Revenue by Country (2016-2021e) & (USD Million)
    Table 105. Europe Dermatology OTC Medications Revenue by Country (2021-2026) & (USD Million)
    Table 106. Europe Dermatology OTC Medications Sales by Type (2016-2021e) & (M Units)
    Table 107. Europe Dermatology OTC Medications Sales by Type (2021-2026) & (M Units)
    Table 108. Europe Dermatology OTC Medications Sales by Application (2016-2021e) & (M Units)
    Table 109. Europe Dermatology OTC Medications Sales by Application (2021-2026) & (M Units)
    Table 110. Asia-Pacific Dermatology OTC Medications Sales by Region (2016-2021e) & (M Units)
    Table 111. Asia-Pacific Dermatology OTC Medications Sales by Region (2021-2026) & (M Units)
    Table 112. Asia-Pacific Dermatology OTC Medications Revenue by Region (2016-2021e) & (USD Million)
    Table 113. Asia-Pacific Dermatology OTC Medications Revenue by Region (2021-2026) & (USD Million)
    Table 114. Asia-Pacific Dermatology OTC Medications Sales by Type (2016-2021e) & (M Units)
    Table 115. Asia-Pacific Dermatology OTC Medications Sales by Type (2021-2026) & (M Units)
    Table 116. Asia-Pacific Dermatology OTC Medications Sales by Application (2016-2021e) & (M Units)
    Table 117. Asia-Pacific Dermatology OTC Medications Sales by Application (2021-2026) & (M Units)
    Table 118. South America Dermatology OTC Medications Sales by Country (2016-2021e) & (M Units)
    Table 119. South America Dermatology OTC Medications Sales by Country (2021-2026) & (M Units)
    Table 120. South America Dermatology OTC Medications Revenue by Country (2016-2021e) & (USD Million)
    Table 121. South America Dermatology OTC Medications Revenue by Country (2021-2026) & (USD Million)
    Table 122. South America Dermatology OTC Medications Sales by Type (2016-2021e) & (M Units)
    Table 123. South America Dermatology OTC Medications Sales by Type (2021-2026) & (M Units)
    Table 124. South America Dermatology OTC Medications Sales by Application (2016-2021e) & (M Units)
    Table 125. South America Dermatology OTC Medications Sales by Application (2021-2026) & (M Units)
    Table 126. Middle East & Africa Dermatology OTC Medications Sales by Country (2016-2021e) & (M Units)
    Table 127. Middle East & Africa Dermatology OTC Medications Sales by Country (2021-2026) & (M Units)
    Table 128. Middle East & Africa Dermatology OTC Medications Revenue by Country (2016-2021e) & (USD Million)
    Table 129. Middle East & Africa Dermatology OTC Medications Revenue by Country (2021-2026) & (USD Million)
    Table 130. Middle East & Africa Dermatology OTC Medications Sales by Type (2016-2021e) & (M Units)
    Table 131. Middle East & Africa Dermatology OTC Medications Sales by Type (2021-2026) & (M Units)
    Table 132. Middle East & Africa Dermatology OTC Medications Sales by Application (2016-2021e) & (M Units)
    Table 133. Middle East & Africa Dermatology OTC Medications Sales by Application (2021-2026) & (M Units)
    Table 134. Direct Channel Pros & Cons
    Table 135. Indirect Channel Pros & Cons
    Table 136. Dermatology OTC Medications Typical Distributors
    Table 137. Dermatology OTC Medications Typical Customers
List of Figures
    Figure 1. Dermatology OTC Medications Picture
    Figure 2. Global Dermatology OTC Medications Sales Market Share by Type in 2020
    Figure 3. External Use
    Figure 4. Oral
    Figure 5. Global Dermatology OTC Medications Sales Market Share by Application in 2020
    Figure 6. Hospital
    Figure 7. Drug Store
    Figure 8. Other
    Figure 9. Global Dermatology OTC Medications Market Size, (USD Million) & (M Units): 2020 VS 2021 VS 2026
    Figure 10. Global Dermatology OTC Medications Market Size and Forecast (2016-2026) & (USD Million)
    Figure 11. Global Dermatology OTC Medications Sales (2016-2026) & (M Units)
    Figure 12. Global Dermatology OTC Medications Price by Type (2016-2026) & (USD/Unit)
    Figure 13. Global Dermatology OTC Medications Production Capacity (2016-2026) & (M Units)
    Figure 14. Global Dermatology OTC Medications Production Capacity by Geographic Region: 2020 VS 2021
    Figure 15. Dermatology OTC Medications Market Drivers
    Figure 16. Dermatology OTC Medications Market Restraints
    Figure 17. Dermatology OTC Medications Market Trends
    Figure 18. Global Dermatology OTC Medications Sales Market Share by Manufacturer in 2020
    Figure 19. Global Dermatology OTC Medications Revenue Market Share by Manufacturer in 2020
    Figure 20. Dermatology OTC Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 21. Top 3 Dermatology OTC Medications Manufacturer (Revenue) Market Share in 2020
    Figure 22. Top 6 Dermatology OTC Medications Manufacturer (Revenue) Market Share in 2020
    Figure 23. Global Dermatology OTC Medications Sales Market Share by Region (2016-2026)
    Figure 24. Global Dermatology OTC Medications Revenue Market Share by Region (2016-2026)
    Figure 25. North America Dermatology OTC Medications Revenue (2016-2026) & (USD Million)
    Figure 26. Europe Dermatology OTC Medications Revenue (2016-2026) & (USD Million)
    Figure 27. Asia-Pacific Dermatology OTC Medications Revenue (2016-2026) & (USD Million)
    Figure 28. South America Dermatology OTC Medications Revenue (2016-2026) & (USD Million)
    Figure 29. Middle East & Africa Dermatology OTC Medications Revenue (2016-2026) & (USD Million)
    Figure 30. Global Dermatology OTC Medications Sales Market Share by Type (2016-2026)
    Figure 31. Global Dermatology OTC Medications Revenue Market Share by Type (2016-2026)
    Figure 32. Global Dermatology OTC Medications Price by Type (2016-2026) & (USD/Unit)
    Figure 33. Global Dermatology OTC Medications Sales Market Share by Application (2016-2026)
    Figure 34. Global Dermatology OTC Medications Revenue Market Share by Application (2016-2026)
    Figure 35. Global Dermatology OTC Medications Price by Application (2016-2026) & (USD/Unit)
    Figure 36. North America Dermatology OTC Medications Sales Market Share by Type (2016-2026)
    Figure 37. North America Dermatology OTC Medications Sales Market Share by Application (2016-2026)
    Figure 38. North America Dermatology OTC Medications Sales Market Share by Country (2016-2026)
    Figure 39. North America Dermatology OTC Medications Revenue Market Share by Country (2016-2026)
    Figure 40. United States Dermatology OTC Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 41. Canada Dermatology OTC Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 42. Mexico Dermatology OTC Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 43. Europe Dermatology OTC Medications Sales Market Share by Type (2016-2026)
    Figure 44. Europe Dermatology OTC Medications Sales Market Share by Application (2016-2026)
    Figure 45. Europe Dermatology OTC Medications Sales Market Share by Country (2016-2026)
    Figure 46. Europe Dermatology OTC Medications Revenue Market Share by Country (2016-2026)
    Figure 47. Germany Dermatology OTC Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 48. France Dermatology OTC Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. United Kingdom Dermatology OTC Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. Russia Dermatology OTC Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Italy Dermatology OTC Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Asia-Pacific Dermatology OTC Medications Sales Market Share by Region (2016-2026)
    Figure 53. Asia-Pacific Dermatology OTC Medications Sales Market Share by Application (2016-2026)
    Figure 54. Asia-Pacific Dermatology OTC Medications Sales Market Share by Region (2016-2026)
    Figure 55. Asia-Pacific Dermatology OTC Medications Revenue Market Share by Region (2016-2026)
    Figure 56. China Dermatology OTC Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Japan Dermatology OTC Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Korea Dermatology OTC Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. India Dermatology OTC Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Southeast Asia Dermatology OTC Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Australia Dermatology OTC Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. South America Dermatology OTC Medications Sales Market Share by Type (2016-2026)
    Figure 63. South America Dermatology OTC Medications Sales Market Share by Application (2016-2026)
    Figure 64. South America Dermatology OTC Medications Sales Market Share by Country (2016-2026)
    Figure 65. South America Dermatology OTC Medications Revenue Market Share by Country (2016-2026)
    Figure 66. Brazil Dermatology OTC Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Argentina Dermatology OTC Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Middle East & Africa Dermatology OTC Medications Sales Market Share by Type (2016-2026)
    Figure 69. Middle East & Africa Dermatology OTC Medications Sales Market Share by Application (2016-2026)
    Figure 70. Middle East & Africa Dermatology OTC Medications Sales Market Share by Country (2016-2026)
    Figure 71. Middle East & Africa Dermatology OTC Medications Revenue Market Share by Country (2016-2026)
    Figure 72. Turkey Dermatology OTC Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Egypt Dermatology OTC Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. Saudi Arabia Dermatology OTC Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. South Africa Dermatology OTC Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 76. Sales Channel: Direct Channel vs Indirect Channel
    Figure 77. Methodology
    Figure 78. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Bayer
GSK
Teva
Johnson & Johnson
Novartis
Mylan
Sun Pharmaceutical
Aurobindo
Galderma
CR SANJIU
Dr. Reddy's
Lupin
Bausch Health
Cipla
Qilu Pharmaceutical
Almirall
Lingrui

Related Reports

Global Dermatology OTC Medications Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Dermatology OTC Medications Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Pharma & Healthcare

The Dermatology OTC Medications market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Dermatology OTC Medications Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Dermatology OTC Medications Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Dermatology drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.

Global Dermatology OTC Medications Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Dermatology OTC Medications Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Dermatology OTC Medications market size was valued at USD 13150 million in 2023 and is forecast to a readjusted size of USD 16350 million by 2030 with a CAGR of 3.2% during review period.

Product Tags

dermatology otc medications

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>